Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Proteasome02:18

The Proteasome

8.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K
Regulated Protein Degradation02:58

Regulated Protein Degradation

7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Proteasome Structure01:17

The Proteasome Structure

735
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
735

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Association of serum 25-hydroxyvitamin D with the risk of depression in individuals with prediabetes and diabetes: A prospective cohort study" [J Nutr Health Aging, 29 (2025) 100556].

The journal of nutrition, health & aging·2026
Same author

Dysregulation of the HSF1-Mediated UPR<sup>mt</sup> Pathway in Colonic Smooth Muscle Cells Drives Motility Dysfunction in Functional Constipation.

Biomolecules·2026
Same author

NAT10 as a central node in cancer biology: integrating epitranscriptomic regulation, metabolic reprogramming, and immune modulation.

Frontiers in immunology·2026
Same author

<i>Dendrobium officinale</i> polysaccharide ameliorates high-fat diet-induced hepatic lipid metabolic disorder via the SIRT6/PGC-1α signaling axis.

Frontiers in nutrition·2026
Same author

Structure characterization assists rational design of polyethyleneglycol diglycidyl ether (PEGDE) substituted hyaluronic acid.

Synthetic and systems biotechnology·2026
Same author

Multiphase enhanced computed tomography features captured by delta radiomics reveal prognosis and tumor heterogeneity in patients with hepatocellular carcinoma treated with transarterial chemoembolization.

Hepatobiliary & pancreatic diseases international : HBPD INT·2026

Related Experiment Video

Updated: Jun 24, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.6K

Phase Separation Enhanced PROTAC for Highly Efficient Protein Degradation.

Xiaolin Yu1, Wenrui Hu1, Hang Dong1

  • 1State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.

Biomacromolecules
|June 3, 2024
PubMed
Summary
This summary is machine-generated.

Phase separation-based PROTACs (PSETACs) enhance protein degradation by forming cellular droplets. This novel approach, delivered via mRNA-LNP, offers a promising therapeutic strategy for targeted protein degradation.

More Related Videos

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.4K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K

Related Experiment Videos

Last Updated: Jun 24, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.6K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.4K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Biomacromolecular condensates enhance biological process efficiency through phase separation.
  • Proteolysis-targeting chimeras (PROTACs) are effective tools for targeted protein degradation.
  • Current PROTAC technology can be improved for enhanced therapeutic applications.

Purpose of the Study:

  • To engineer PROTACs that leverage phase separation for enhanced protein degradation.
  • To investigate the efficacy of phase separation-enhanced PROTACs (PSETACs) in degrading target proteins.
  • To establish a novel intracellular delivery method for PSETACs using mRNA-LNP for potential therapeutic use.

Main Methods:

  • Incorporation of an intrinsically disordered region into PROTACs to induce phase separation (PSETAC).
  • Assessing PSETAC-induced target protein droplet formation and degradation efficiency in cells.
  • Utilizing a nucleus-targeting domain for nuclear protein degradation with PSETAC.
  • Intracellular delivery of PSETAC via lipid nanoparticle-encapsulated mRNA (mRNA-LNP).

Main Results:

  • PSETACs formed target protein droplets, significantly increasing degradation efficiency compared to standard PROTACs.
  • PSETACs with a nucleus-targeting domain successfully degraded nuclear proteins.
  • Intracellular delivery of PSETAC using mRNA-LNP enabled endogenous target protein degradation.

Conclusions:

  • PSETACs represent a novel strategy to enhance protein degradation through biomacromolecular phase separation.
  • The PSETAC mRNA-LNP method provides a potentially translatable and safe therapeutic approach.
  • This technology holds promise for developing new clinical applications based on PROTACs for various diseases.